Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Jian Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5772-151X; OpenAlex author ID A5101621355. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2016: 2 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 9

  1. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1β axis. Co-author DOI 10.1016/j.canlet.2023.216403↗
  2. RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. Co-author DOI 10.1007/s13258-022-01217-0↗
  3. COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2022.09.049↗
  4. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.omtn.2021.06.001↗
  5. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.682969↗
  6. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Co-author DOI 10.18632/oncotarget.17999↗
  7. Methylation of BNIP3 in pancreatic cancer inhibits the induction of mitochondrial-mediated tumor cell apoptosis. Co-author DOI 10.18632/oncotarget.18736↗
  8. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer. Co-author DOI 10.1186/s13046-016-0298-y↗
  9. Expression and clinical significance of glucose transporter-1 in pancreatic cancer. First author DOI 10.3892/ol.2016.4586↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Zhou · 6 shared papers, 2016–2022 · strength 0.52
  2. Yongzheng Li · 3 shared papers, 2021–2023 · strength 0.46
  3. Zhiyao Fan · 3 shared papers, 2021–2023 · strength 0.46
  4. Hanxiang Zhan · 3 shared papers, 2021–2023 · strength 0.46
  5. Dechun Li · 4 shared papers, 2016–2022 · strength 0.34
  6. Yi Zhang · 4 shared papers, 2016–2022 · strength 0.34
  7. Dongming Zhu · 3 shared papers, 2016–2022 · strength 0.31
  8. Zhaowei Sun · 2 shared papers, 2021–2022 · strength 0.27
  9. Yuchen Tang · 2 shared papers, 2021–2022 · strength 0.26
  10. Bin Yi · 2 shared papers, 2021–2022 · strength 0.26
  11. Yujie Huang · 2 shared papers, 2021–2022 · strength 0.26
  12. Ye Li · 3 shared papers, 2016–2021 · strength 0.25
  13. Dongming Zhu · 3 shared papers, 2016–2017 · strength 0.20
  14. Guangyong Zhang · 1 shared paper, 2023 · strength 0.19
  15. Yuanyuan Jiang · 1 shared paper, 2022 · strength 0.15
  16. Qiuhua Liu · 1 shared paper, 2022 · strength 0.13
  17. Jun Yao · 1 shared paper, 2022 · strength 0.13
  18. Zixiang Zhang · 1 shared paper, 2022 · strength 0.13
  19. Haoran Li · 1 shared paper, 2021 · strength 0.12
  20. Peng Du · 1 shared paper, 2021 · strength 0.12
  21. Bingyuan Zhang · 1 shared paper, 2021 · strength 0.12
  22. Sanyuan Hu · 1 shared paper, 2021 · strength 0.12
  23. Bin Zhou · 1 shared paper, 2021 · strength 0.12
  24. Yunshan Wang · 1 shared paper, 2021 · strength 0.12
  25. Zixiang Zhang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.